Literature DB >> 15529366

Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.

Frank Buttgereit1, Rainer H Straub, Martin Wehling, Gerd-Rüdiger Burmester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15529366     DOI： 10.1002/art.20583

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  69 in total

1.  High-dose intravenous corticosteroids for ocular inflammatory diseases.

Authors:  Leon D Charkoudian; Gui-shuang Ying; Siddharth S Pujari; Sapna Gangaputra; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2012-04       Impact factor: 3.070

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 3.  [Current insights into the development of new glucocorticoid receptor ligands].

Authors:  F Buttgereit; I-H Song; R H Straub; G-R Burmester
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

Review 4.  [Glucocorticoid therapy in collagen diseases diseases].

Authors:  L Unger; M Kayser; M Enderlein; K Manger; H Nüsslein
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

5.  Inflammation, glucocorticoids and risk of cardiovascular disease.

Authors:  Frank Buttgereit; Gerd-Rüdiger Burmester; Brian J Lipworth
Journal:  Nat Clin Pract Rheumatol       Date:  2008-12-02

Review 6.  [Glucocorticoids in rheumatology].

Authors:  R Dziurla; F Buttgereit
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

Review 7.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

8.  [Disease-modifying effects of glucocorticoids in rheumatoid arthritis].

Authors:  F Buttgereit; G Burmester; J W Bijlsma
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

9.  Membrane-Associated Effects of Glucocorticoid on BACE1 Upregulation and Aβ Generation: Involvement of Lipid Raft-Mediated CREB Activation.

Authors:  Gee Euhn Choi; Sei-Jung Lee; Hyun Jik Lee; So Hee Ko; Chang Woo Chae; Ho Jae Han
Journal:  J Neurosci       Date:  2017-08-03       Impact factor: 6.167

10.  Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy.

Authors:  Jungyeon Hwang; Kathleen Rodgers; James C Oliver; Thomas Schluep
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.